Recurrent Respiratory Papillomatosis
Symptoms, Doctors, Treatments, Advances & More

Recurrent Respiratory Papillomatosis Overview

Save information for later
Sign Up

Learn About Recurrent Respiratory Papillomatosis

What is the definition of Recurrent Respiratory Papillomatosis?
Recurrent respiratory papillomatosis (RRP) is a rare viral disease where tumors (papillomas) grow in the air passages leading from the nose and mouth into the lungs (respiratory tract). There are two types, a juvenile-onset form and an adult-onset form. The tumors can cause a hoarse voice, chronic cough, and difficulty breathing. They may vary in size and grow very quickly, and may grow back even when removed. These tumors rarely become cancerous, but can cause long-term airway and voice complications. RRP is caused by two types of human papillomavirus (HPV), called HPV 6 and HPV 11. It is transmitted from an infected mother to her baby through the placenta or through the birth canal. HPV can also be transmitted from one adult to another through oral sex. The HPV vaccine can help prevent infection.
What are the alternative names for Recurrent Respiratory Papillomatosis?
  • Recurrent respiratory papillomatosis
  • AORRP (type)
  • Adult-onset recurrent respiratory papillomatosis (type)
  • JORRP (type)
  • Juvenile laryngeal papilloma
  • Juvenile-onset recurrent respiratory papillomatosis (type)
  • Laryngeal papilloma, recurrent
  • RRP
  • Respiratory papillomatosis, recurrent
Who are the top Recurrent Respiratory Papillomatosis Local Doctors?
Elite in Recurrent Respiratory Papillomatosis
Dr. Adam Klein
Otolaryngology
Elite in Recurrent Respiratory Papillomatosis
Dr. Adam Klein
Otolaryngology

Emory Clinic Urology At Midtown

550 Peachtree St NE Fl 9, 
Atlanta, GA 
404-778-3381
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Adam Klein is an Otolaryngologist in Atlanta, Georgia. Dr. Klein is rated as an Elite provider by MediFind in the treatment of Recurrent Respiratory Papillomatosis. His top areas of expertise are Recurrent Respiratory Papillomatosis, Spasmodic Dysphonia, Laryngitis, Laryngectomy, and Tissue Biopsy.

Elite in Recurrent Respiratory Papillomatosis
Dr. Allan Abramson
Otolaryngology
Elite in Recurrent Respiratory Papillomatosis
Dr. Allan Abramson
Otolaryngology

Long Island Jewish Medical Center

430 Lakeville Rd, 
New Hyde Park, NY 
718-470-4560
Languages Spoken:
English
See accepted insurances

Allan Abramson is an Otolaryngologist in New Hyde Park, New York. Dr. Abramson is rated as an Elite provider by MediFind in the treatment of Recurrent Respiratory Papillomatosis. His top area of expertise is Recurrent Respiratory Papillomatosis.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Recurrent Respiratory Papillomatosis
Yang C. Xiao
Elite in Recurrent Respiratory Papillomatosis
Yang C. Xiao
238 Shang Mayuanling, Xiangya Road, 
Changsha, CN 

Yang Xiao practices in Changsha, China. Mr. Xiao is rated as an Elite expert by MediFind in the treatment of Recurrent Respiratory Papillomatosis. His top areas of expertise are Recurrent Respiratory Papillomatosis, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), Spinal Fusion, and Endoscopy.

View All Doctors
What are the latest Recurrent Respiratory Papillomatosis Clinical Trials?
A Phase 1 Study Of The Safety And Immunogenicity Of Peptide-loaded Autologous Dendritic Cell Vaccination In Recurrent Respiratory Papillomatosis (RRP) Patients
A Phase 1 Study Of The Safety And Immunogenicity Of Peptide-loaded Autologous Dendritic Cell Vaccination In Recurrent Respiratory Papillomatosis (RRP) Patients
Enrollment Status: Recruiting
Publish Date: January 05, 2026
Intervention Type: Biological
Study Phase: Phase 1

Summary: The purpose of this study is to evaluate the safety and immunogenicity of autologous DC vaccine in recurrent respiratory papillomatosis patients

Match to trials
Find the right clinical trials for you in under a minute
Get started
Open-Label Study of Zopapogene Imadenovec Retreatment and Vector Shedding Evaluation in Adult Patients With Recurrent Respiratory Papillomatosis
Open-Label Study of Zopapogene Imadenovec Retreatment and Vector Shedding Evaluation in Adult Patients With Recurrent Respiratory Papillomatosis
Enrollment Status: Recruiting
Publish Date: December 15, 2025
Intervention Type: Drug
Study Phase: Phase 4

Summary: This open-label study evaluates safety, vector shedding, and retreatment efficacy of Zopapogene imadenovec (Zopa) in adults with recurrent respiratory papillomatosis (RRP). Two cohorts will be enrolled (n=30): Cohort 1 to assess the magnitude and duration of adenoviral vector shedding in urine, feces, skin, and nasal tissue; Cohort 2 to assess the complete response rate following retreatment.

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center